[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 11, Issue 3 (Summer 2022) ::
aumj 2022, 11(3): 280-288 Back to browse issues page
The Effect of Lymphocyte Therapy on the Expression of MicroRNAs in Women with Recurrent Pregnancy Loss
Sanam Dolati , Mohammad Sadegh Soltani-Zangbar , Jalal Etemadi Khiavi , Maryam Mojahedi, Shahla Danaii, Javad Ahmadian heris , Mehdi Yousefi
Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Abstract:   (139 Views)
Background: Recurrent Pregnancy Loss (RPL) is 2 or more recurrent miscarriages before the twentieth week, which occurs in 2-5% of women of gestational age. Considering the significant role of the immune system in the process of a successful pregnancy, it is expected that in addition to the common and well-known treatments used for patients with recurrent miscarriage to date, intracutaneous lymphocyte therapy will also be effective.
Methods: 30 patients with RPL with immunological disorders, and 30 patients in a control group consisting of healthy women with a history of successful pregnancies were included in the study. After receiving blood samples and initial examinations, people with RPL received lymphocytic treatment. Before and after the intervention, the expression levels of miR-146a, miR-10a, miR-106b, and miR-25 were measured in both groups and the differences caused by the effects of this intervention were examined.
Results: The expression of anti-inflammatory miR-146a and miR-10a, in women with RPL showed a significant increase after receiving lymphocyte treatment compared to before treatment. While the expression of pro-inflammatory miR-106b and miR-25 showed a significant decrease after receiving lymphocytes compared to before treatment.
Conclusion: The aim of intradermal lymphocyte therapy is to increase the maternal immune system's tolerance to paternal antigens in the fetus and to modulate inflammatory responses in pregnant women with RPL. According to the results of this study, this method can be used to reduce inflammation in women with recurrent miscarriage.
 
Keywords: Recurrent Pregnancy Loss, Lymphocyte therapy, MicroRNA, Inflammation.
Full-Text [PDF 598 kb]   (47 Downloads)    
Type of Study: Research | Subject: Special
Received: 2022/05/10 | Accepted: 2022/07/01 | Published: 2022/07/01
Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Dolati S, Soltani-Zangbar M S, Etemadi Khiavi J, Mojahedi M, Danaii S, Ahmadian heris J et al . The Effect of Lymphocyte Therapy on the Expression of MicroRNAs in Women with Recurrent Pregnancy Loss. aumj. 2022; 11 (3) :280-288
URL: http://aums.abzums.ac.ir/article-1-1541-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 11, Issue 3 (Summer 2022) Back to browse issues page
نشریه دانشگاه علوم پزشکی البرز Alborz University Medical Journal
Persian site map - English site map - Created in 0.05 seconds with 30 queries by YEKTAWEB 4414